𧬠Vera Therapeutics $VERA +6% premarket β traders loading up ahead of Tuesday FDA PDUFA decision
Vera Therapeutics is up 6% in early trading this morning with a make-or-break FDA PDUFA date set for tomorrow, July 7. This is a classic binary-event setup where approval could send shares surging while a Complete Response Letter could crush them. The stock is moving purely on anticipation right now β no new data yet. Would you hold through the decision or take the premarket pop and walk away? Not financial advice.